Oxler Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.85M | Sell |
9,499
-385
| -4% | -$156K | 1.21% | 18 |
|
2025
Q1 | $4.92M | Sell |
9,884
-55
| -0.6% | -$27.4K | 1.73% | 18 |
|
2024
Q4 | $5.17M | Sell |
9,939
-58
| -0.6% | -$30.2K | 1.7% | 16 |
|
2024
Q3 | $6.18M | Buy |
9,997
+52
| +0.5% | +$32.2K | 2.15% | 15 |
|
2024
Q2 | $5.5M | Buy |
9,945
+6
| +0.1% | +$3.32K | 2.04% | 14 |
|
2024
Q1 | $5.78M | Buy |
9,939
+2,365
| +31% | +$1.37M | 2.26% | 13 |
|
2023
Q4 | $4.02M | Sell |
7,574
-2,514
| -25% | -$1.33M | 3.34% | 10 |
|
2023
Q3 | $5.12M | Sell |
10,088
-248
| -2% | -$126K | 2.57% | 10 |
|
2023
Q2 | $5.4M | Sell |
10,336
-146
| -1% | -$76.3K | 2.57% | 9 |
|
2023
Q1 | $6.05M | Sell |
10,482
-54
| -0.5% | -$31.1K | 2.99% | 9 |
|
2022
Q4 | $5.81M | Sell |
10,536
-227
| -2% | -$125K | 3.13% | 8 |
|
2022
Q3 | $5.47M | Sell |
10,763
-26
| -0.2% | -$13.2K | 3.06% | 7 |
|
2022
Q2 | $5.86M | Sell |
10,789
-19
| -0.2% | -$10.3K | 2.82% | 9 |
|
2022
Q1 | $6.38M | Buy |
10,808
+4
| +0% | +$2.36K | 2.88% | 9 |
|
2021
Q4 | $7.21M | Sell |
10,804
-110
| -1% | -$73.4K | 2.99% | 8 |
|
2021
Q3 | $6.24M | Sell |
10,914
-15
| -0.1% | -$8.57K | 2.75% | 8 |
|
2021
Q2 | $5.51M | Sell |
10,929
-25
| -0.2% | -$12.6K | 2.4% | 9 |
|
2021
Q1 | $5M | Buy |
10,954
+120
| +1% | +$54.8K | 2.53% | 8 |
|
2020
Q4 | $5.05M | Buy |
+10,834
| New | +$5.05M | 2.84% | 8 |
|